Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 10, 2018
Participant satisfaction with dementia prevention research: Results from Home-Based Assessment trialMary Sano, Susan Egelko, Carolyn W Zhu, et al.
The New England Journal of Medicine|April 15, 2005
Vitamin E and donepezil for the treatment of mild cognitive impairmentRonald C Petersen, Ronald G Thomas, Michael Grundman, et al.
Alzheimer Disease and Associated Disorders|November 30, 2006
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease CentersJohn C Morris, Sandra Weintraub, Helena C Chui, et al.
AAPS Pharmscitech|February 17, 2017
Recommended Best Practices for Process Monitoring Instrumentation in Pharmaceutical Freeze Drying-2017Steven Nail, Serguei Tchessalov, Evgenyi Shalaev, et al.
Archives of Neurology|May 11, 2005
Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individualsChristopher M Clark, Charles DeCarli, Dan Mungas, et al.
Alzheimer Disease and Associated Disorders|May 29, 2009
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test batterySandra Weintraub, David Salmon, Nathaniel Mercaldo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2019
A randomized clinical trial to evaluate home-based assessment of people over 75 years oldMary Sano, Carolyn W Zhu, Jeffrey Kaye, et al.
Alzheimer Disease and Associated Disorders|December 15, 2017
Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS)Sandra Weintraub, Lilah Besser, Hiroko H Dodge, et al.
The Lancet. Neurology|May 19, 2007
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyHoward H Feldman, Steven Ferris, Bengt Winblad, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Pageof 6